Plain-English translation of NCT07631572 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing cesium-131 brachytherapy, a form of internal radiation therapy using grain-of-rice-sized radioactive seeds implanted directly into or near where your cancer has returned in the vagina. The seeds give off radiation to kill cancer cells for a short time—most radiation is gone within a few weeks—while the seeds themselves stay in your body but become inactive quickly. Researchers hope this treatment can help patients with recurrent cervical or endometrial cancer avoid major pelvic surgery.
When cervical or endometrial cancer comes back in the vagina after previous pelvic radiation, the main treatment option has been major surgery to remove much of the pelvic organs, which carries serious risks and side effects. This trial exists to test whether this gentler radiation technique can offer an effective alternative that preserves your organs and quality of life.
You likely qualify if…
You likely don't qualify if…
If you qualify for this trial, your doctor will surgically implant the tiny radioactive cesium-131 seeds directly into or near your cancer in the vagina—a procedure similar to other internal radiation treatments. After implantation, the seeds will deliver radiation to kill cancer cells over a short period of time. You will have follow-up visits to monitor how well the treatment is working and to watch for any side effects, though the exact schedule will be determined by your treatment team.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States